RNY3 and prostate neoplasm: However, we note three exceptions from the overall trend: the highest levels of hY1, hY3 and hY4 overexpression were observed in kidney tumours, a very high level of hY5 overexpression in lung tumours, and no or borderline overexpression was observed for hY4 RNA in bladder, lung and prostate tumours (Figure 3).